Trastuzumab Unknown Status Phase 2 Trials for Hepatic Metastases / Metastatic Breast Cancer (MBC) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01387295Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease
NCT01387373Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer
NCT00250874Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer